RTOG 0815: A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer

CTO - 6078
Cancer Genitourinary/ Prostate
  1. Males at least 18 years of age
  2. Histologically confirmed adenocarcinoma of the prostate diagnosed within the past 180 days
Tiffany Pearce